For the Inventor, By the Inventor

Enter assignee name

Roseland, NJ, United States of America

Emisphere Technologies, Inc.

USPTO Granted Patents = 183

CIPO Patents = 86

EPO Patents = 41

Trademarks = 2

Forward Citations = 5,301

Loading Chart...

Loading Chart...

202 inventors (with patents filed for the assignee):

Andrea Leone-Bay (67 out of 118 patents)

Sam J Milstein (51 out of 53 patents)

Donald J Sarubbi (43 out of 45 patents)

4. David Gschneidner (26 out of 29 patents)

5. Shingai Majuru (24 out of 28 patents)

6. Koc-Kan Ho (23 out of 50 patents)

7. Nai Fang Wang (21 out of 21 patents)

8. Evgueni N Barantsevitch (19 out of 19 patents)

9. Eric Yanjun Wang (19 out of 24 patents)

10. Harry R Leipold (18 out of 19 patents)

11. Pingwah Tang (15 out of 15 patents)

12. Steven Minh Dinh (14 out of 18 patents)

13. Doris C O'Toole (12 out of 15 patents)

14. Michael M Goldberg (12 out of 13 patents)

15. Martin L Kantor (12 out of 16 patents)

Core Competencies:

Salcaprozate Sodium

Active Agent Delivery

Crystalline Polymorphic Forms

Phenylalkylcarboxylic Acid

Topical Cromolyn Formulations

Oral Insulin Therapies

GLP-1 Formulations

Pharmaceutical Dosage Forms

Gallium Nitrate Formulations

Acyclovir Formulations

Peptide YY Delivery

Bone Related Diseases Treatment

183 patents: Sort by Forward Citations

1. 10875826 - Process for the manufacture of SNAC (salcaprozate sodium) (2020-12-29),

2. RE48164 - Compounds and compositions for delivering active agents (2020-08-17),

3. 10744105 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate (2020-08-18),

4. 10456472 - Phenylalkylcarboxylic acid delivery agents (2019-10-29),

5. 10188621 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate (2019-01-29),

6. 9873667 - Arylsulfanyl compounds and compositions for delivering active agents (2018-01-23),

7. 9750710 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate (2017-09-05),

8. 9498487 - Topical cromolyn formulations (2016-11-22),

9. 9458089 - Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents (2016-10-04),

10. 9402864 - Oral iron deficiency therapy (2016-08-02),

11. 9399054 - Compositions for delivering peptide YY and PYY agonists (2016-07-26),

12. 9370492 - Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers (2016-06-21),

13. 9364502 - Gallium nitrate formulations (2016-06-14),

14. 9345725 - Pharmaceutical formulations of gallium salts (2016-05-24),

15. 9345722 - Pharmaceutical formulations for the treatment of alzheimer's disease (2016-05-24),

Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on developing and delivering innovative oral drug delivery solutions. Their proprietary Eligen® Technology enables the oral delivery of therapeutics that are typically administered through injection or infusion, enhancing patient convenience and compliance. Emisphere's expertise lies in improving the delivery, absorption, and therapeutic performance of drugs across a wide range of therapeutic areas. Through collaborations and partnerships, they aim to bring their technology to a range of pharmaceutical and biotech companies worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

183 Patents

#2 in Roseland, NJ

#100 in New Jersey

#2,141 in US

#4,430 in the World

Roseland, NJ, United States of America

Emisphere Technologies, Inc.

Forward Citations = 5,301

202 inventors:

Andrea Leone-Bay (67 out of 118 patents)

Sam J Milstein (51 out of 53 patents)

Donald J Sarubbi (43 out of 45 patents)

4. David Gschneidner (26 out of 29 patents)

5. Shingai Majuru (24 out of 28 patents)

Please report any incorrect information to support@idiyas.com

Loading…